- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Mediators of Inflammation
Volume 2010 (2010), Article ID 171023, 7 pages
Resistance Exercise Training-Induced Muscle Hypertrophy Was Associated with Reduction of Inflammatory Markers in Elderly Women
1Research Team for Social Participation and Health Promotion, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashi, Tokyo 173-0015, Japan
2Consolidated Research Institute for Advanced Science and Medical Care, Waseda University, 513 Wasedatsurumakicho Shinjuku, Tokyo 162-0041, Japan
3School of Physical Education, Tokai University, 1117 Kitakaname, Hiratsuka, Kanagawa 259-1292, Japan
4Faculty of Human Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa, Saitama 359-1192, Japan
Received 20 July 2010; Revised 21 October 2010; Accepted 1 December 2010
Academic Editor: Giamila Fantuzzi
Copyright © 2010 Kishiko Ogawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- N. Khuseyinova and W. Koenig, “Biomarkers of outcome from cardiovascular disease,” Current Opinion in Critical Care, vol. 12, no. 5, pp. 412–419, 2006.
- W. Koenig, N. Khuseyinova, J. Baumert et al., “Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2745–2751, 2006.
- P. M. Ridker, N. Rifai, M. J. Stampfer, and C. H. Hennekens, “Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men,” Circulation, vol. 101, no. 15, pp. 1767–1772, 2000.
- P. M. Ridker, N. Rifai, M. Pfeffer, F. Sacks, S. Lepage, and E. Braunwald, “Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction,” Circulation, vol. 101, no. 18, pp. 2149–2153, 2000.
- T. B. Harris, L. Ferrucci, R. P. Tracy et al., “Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly,” American Journal of Medicine, vol. 106, no. 5, pp. 506–512, 1999.
- P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000.
- P. Libby and P. M. Ridker, “Novel inflammatory markers of coronary risk: theory versus practice,” Circulation, vol. 100, no. 11, pp. 1148–1150, 1999.
- K. Ogawa, K. Suzuki, O. Mitsuharu, K. Yamazaki, and S. Shinkai, “The association of elevated reactive oxygen species levels from neutrophils with low-grade inflammation in the elderly,” Immunity and Ageing, vol. 5, Article ID 13, 2008.
- P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002.
- H. Länsimies-Antikainen, A. M. Pietilä, T. Laitinen, V. Kiviniemi, and R. Rauramaa, “Is informed consent related to success in exercise and diet intervention as evaluated at 12 months? DR's EXTRA study,” BMC Medical Ethics, vol. 11, no. 1, Article ID 9, 2010.
- Y. Tajiri, T. Kato, H. Nakayama, and K. Yamada, “Reduction of skeletal muscle, especially in lower limbs, in Japanese type 2 diabetic patients with Insulin resistance and cardiovascular risk factors,” Metabolic Syndrome and Related Disorders, vol. 8, no. 2, pp. 137–142, 2010.
- D. König, P. Deibert, K. Winkler, and A. Berg, “Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease,” Exercise Immunology Review, vol. 11, pp. 97–107, 2005.
- D. B. Reuben, L. Judd-Hamilton, T. B. Harris, and T. E. Seeman, “The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur studies of successful aging,” Journal of the American Geriatrics Society, vol. 51, no. 8, pp. 1125–1130, 2003.
- L. H. Colbert, M. Visser, E. M. Simonsick et al., “Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study,” Journal of the American Geriatrics Society, vol. 52, no. 7, pp. 1098–1104, 2004.
- D. R. Taaffe, T. B. Harris, L. Ferrucci, J. Rowe, and T. E. Seeman, “Cross-sectional and prospective relationships of interleukin-6 and c-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging,” Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 55, no. 12, pp. M709–M715, 2000.
- M. A. Spruit, R. Gosselink, T. Troosters, A. Kasran, M. Van Vliet, and M. Decramer, “Low-grade systemic inflammation and the response to exercise training in patients with advanced COPD,” Chest, vol. 128, no. 5, pp. 3183–3190, 2005.
- P. V. Tisi, M. Hulse, A. Chulakadabba, P. Gosling, and C. P. Shearman, “Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response?” European Journal of Vascular and Endovascular Surgery, vol. 14, no. 5, pp. 344–350, 1997.
- F. Mattusch, B. Dufaux, O. Heine, I. Mertens, and R. Rost, “Reduction of the plasma concentration of C-reactive protein following nine months of endurance training,” International Journal of Sports Medicine, vol. 21, no. 1, pp. 21–24, 2000.
- J. S. Greiwe, C. Bo, D. C. Rubin, K. E. Yarasheski, and C. F. Semenkovich, “Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans,” FASEB Journal, vol. 15, no. 2, pp. 475–482, 2001.
- M. Visser, S. M. F. Pluijm, V. S. Stel, R. J. Bosscher, and D. J. H. Deeg, “Physical activity as a determinant of change in mobility performance: the longitudinal aging study Amsterdam,” Journal of the American Geriatrics Society, vol. 50, no. 11, pp. 1774–1781, 2002.
- M. A. Schrager, E. J. Metter, E. Simonsick et al., “Sarcopenic obesity and inflammation in the InCHIANTI study,” Journal of Applied Physiology, vol. 102, no. 3, pp. 919–925, 2007.
- H. Bruunsgaard, E. Bjerregaard, M. Schroll, and B. K. Pedersen, “Muscle strength after resistance training is inversely correlated with baseline levels of soluble tumor necrosis factor receptors in the oldest old,” Journal of the American Geriatrics Society, vol. 52, no. 2, pp. 237–241, 2004.
- Z. Xing, J. Gauldie, G. Cox et al., “IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses,” Journal of Clinical Investigation, vol. 101, no. 2, pp. 311–320, 1998.
- R. Starkie, S. R. Ostrowski, S. Jauffred, M. Febbraio, and B. K. Pedersen, “Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans,” The FASEB Journal, vol. 17, no. 8, pp. 884–886, 2003.
- C. Keller, P. Keller, M. Giralt, J. Hidalgo, and B. K. Pedersen, “Exercise normalises overexpression of TNF-α in knockout mice,” Biochemical and Biophysical Research Communications, vol. 321, no. 1, pp. 179–182, 2004.
- I. Bautmans, M. Lambert, and T. Mets, “The six-minute walk test in community dwelling elderly: influence of health status,” BMC Geriatrics, vol. 4, Article ID 6, 9 pages, 2004.
- K. Sanada, C. F. Kearns, T. Midorikawa, and T. Abe, “Prediction and validation of total and regional skeletal muscle mass by ultrasound in Japanese adults,” European Journal of Applied Physiology, vol. 96, no. 1, pp. 24–31, 2006.
- S. W. J. Lamberts, A. W. Van Den Beld, and A. J. Van Der Lely, “The endocrinology of aging,” Science, vol. 278, no. 5337, pp. 419–424, 1997.
- A. J. Dirks and C. Leeuwenburgh, “Tumor necrosis factor α signaling in skeletal muscle: effects of age and caloric restriction,” Journal of Nutritional Biochemistry, vol. 17, no. 8, pp. 501–508, 2006.
- A. M. Petersen, P. Plomgaard, C. P. Fischer, T. Ibfelt, B. K. Pedersen, and G. Van Hall, “Acute moderate elevation of TNF-α does not affect systemic and skeletal muscle protein turnover in healthy humans,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 294–299, 2009.
- A. Artl, G. Marsche, S. Lestavel, W. Sattler, and E. Malle, “Role of serum amyloid A during metabolism of acute-phase HDL by macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 3, pp. 763–772, 2000.
- B. D. Johnson, K. E. Kip, O. C. Marroquin et al., “Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE),” Circulation, vol. 109, no. 6, pp. 726–732, 2004.
- R. Kisilevsky and S. P. Tam, “Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease,” Pediatric Pathology and Molecular Medicine, vol. 21, no. 3, pp. 291–305, 2002.
- A. G. Pockley, U. De Faire, R. Kiessling, C. Lemne, T. Thulin, and J. Frostegård, “Circulating heat shock protein and heat shock protein antibody levels in established hypertension,” Journal of Hypertension, vol. 20, no. 9, pp. 1815–1820, 2002.
- Y. C. Chan, N. Shukla, M. Abdus-Samee et al., “Anti-heat-shock protein 70 kDa antibodies in vascular patients,” European Journal of Vascular and Endovascular Surgery, vol. 18, no. 5, pp. 381–385, 1999.
- G. Gromadzka, J. Zielińska, D. Ryglewicz, U. Fiszer, and A. Członkowska, “Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia,” Cerebrovascular Diseases, vol. 12, no. 3, pp. 235–239, 2001.
- J. M. Saxton, I. Zwierska, K. Hopkinson et al., “Effect of upper- and lower-limb exercise training on circulating soluble adhesion molecules, hs-CRP and stress proteins in patients with intermittent claudication,” European Journal of Vascular and Endovascular Surgery, vol. 35, no. 5, pp. 607–613, 2008.
- Y. O. Shin, J. S. Bae, J. B. Lee et al., “Effect of cardiac rehabilitation and statin treatment on anti-HSP antibody titers in patients with coronary artery disease after percutaneous coronary intervention,” International Heart Journal, vol. 47, no. 5, pp. 671–682, 2006.
- H. Singh-Jasuja, N. Hilf, H. U. Scherer et al., “The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells,” Cell Stress and Chaperones, vol. 5, no. 5, pp. 462–470, 2000.
- K. Ogawa and E. Fehrenbach, “Exercise intensity and duration affect blood-soluble HSP72,” in Heat Shock Protein and Whole Body Physiology, A. A. Asea and B. K. Pedersen, Eds., pp. 253–265, Springer, New York, NY, USA, 2010.
- L. A. Consitt, J. L. Copeland, and M. S. Tremblay, “Endogenous anabolic hormone responses to endurance versus resistance exercise and training in women,” Sports Medicine, vol. 32, no. 1, pp. 1–22, 2002.
- G. Jahreis, E. Kauf, G. Fröhner, and H. E. Schmidt, “Influence of intensive exercise on insulin-like growth factor I, thyroid and steroid hormones in female gymnasts,” Growth Regulation, vol. 1, no. 3, pp. 95–99, 1991.
- L. Rosendal, H. Langberg, A. Flyvbjerg, J. Frystyk, H. Ørskov, and M. Kjæer, “Physical capacity influences the response of insulin-like growth factor and its binding proteins to training,” Journal of Applied Physiology, vol. 93, no. 5, pp. 1669–1675, 2002.
- D. Nemet, P. H. Connolly, A. M. Pontello-Pescatello et al., “Negative energy balance plays a major role in the IGF-I response to exercise training,” Journal of Applied Physiology, vol. 96, no. 1, pp. 276–282, 2004.